Somatic and autonomic small fiber neuropathy induced by bortezomib therapy: an immunofluorescence study

@article{Giannoccaro2010SomaticAA,
  title={Somatic and autonomic small fiber neuropathy induced by bortezomib therapy: an immunofluorescence study},
  author={Maria Pia Giannoccaro and Vincenzo Donadio and Carolina Gomis P{\`e}rez and Walter Borsini and Vitantonio Di Stasi and Rocco Liguori},
  journal={Neurological Sciences},
  year={2010},
  volume={32},
  pages={361-363}
}
Bortezomib is a new chemotherapeutic agent approved for the treatment of relapsed/refractory and newly diagnosed multiple myeloma. One of the major side effects of bortezomib is a peripheral length-dependent sensory axonal neuropathy and, less frequently, a small fiber neuropathy. Autonomic symptoms like postural dizziness, syncope, diarrhoea, ileus… CONTINUE READING